Combining neoadjuvant radiotherapy with SBRT followed by IOeRT boost at surgery appears feasible and safe. This strategy demonstrated high local control and low toxicity following the resection of pancreatic cancer. However, longer follow-up and larger-scale studies are necessary.

G. Cornejo, A. Pikarsky, P. Blumenfeld, M. Wygoda, J. Feldman, A. Hubert,L. Appelbaum-Pikarsky, A. Khalaila,A. Imam, G. Zamir

Introduction

• The prognosis following surgery for pancreatic cancer remains poor, local recurrence is common and negatively impacts the survival rate.

• To improve local control and potentially improve survival, we have adopted a strategy of adding intra-operative electron radiation therapy (IOeRT) to selected patients undergoing pancreatic resection for pancreatic cancer.

• Its main advantage is the ability to locally deliver a high radiation dose, therefore boosting the effect of pre-op stereotactic body radiation therapy (SBRT).

• Here we report our initial experience with this treatment modality.

Methodology

• This is a retrospective review of patients who were at risk of not achieving satisfactory resection margins by surgery alone.

• They were treated with pre-operativeSBRT and neoadjuvant therapy.

• 2-4 weeks later patients underwent surgical intervention (Whipple, distal pancreatectomy).

• Immediately after resection IOeRT was delivered to a dose of 10-15 Gy at the tumor bed deemed at high risk for recurrence.

Read the findings>> here

Skip to content